Concepedia
Statistics
Publications
61
Citations
3.2K
H-Index
32
Active since
1992
Affiliations
University of Oslo(Current)
Oslo University Hospital
Norwegian Cancer Society
Oncoinvent (Norway)
Bayer (Norway)
Roy H. Larsen is an author at University of Oslo specializing in radionuclide therapy, medicine, and oncology.
Publications per year
1992–2025
First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases
Sten Nilsson, Roy H. Larsen, Sophie D. Fosså et al. · Clinical Cancer Research · 2005 · 433 citations
Medicine, Oncology, Radiation Oncology +17
Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.
Gjermund Henriksen, Knut Breistøl, Øyvind S. Bruland et al. · PubMed · 2002 · 281 citations
Medicine, Oncology, Pharmacology +16
Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice.
Gjermund Henriksen, Darrell R. Fisher, John C. Roeske et al. · PubMed · 2003 · 251 citations
Medicine, Nuclear Medicine, Pharmacokinetics +16
Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction
Roy H. Larsen, Bruce W. Wieland, Michael R. Zalutsky · Applied Radiation and Isotopes · 1996 · 104 citations
Natural Sciences, Nuclear Engineering, Physics +7
Sterically stabilized liposomes as a carrier for α-emitting radium and actinium radionuclides
Gjermund Henriksen, Bent W. Schoultz, Terje E. Michaelsen et al. · Nuclear Medicine and Biology · 2004 · 99 citations
Pharmacy, Chemistry, Molecular Pharmaceutics +14
1–5 of 61